Physician profile
Amy R Pohlman
NPI 1033131388
$947.26
in general payments reported to CMS, 2019-2025
13 companies · $41.93 in 2025
The $41.93 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $75.78 · 2022: $291 · 2023: $321 · 2024: $218 · 2025: $41.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $580.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $175.82 | 2021-2024 | Mounjaro, Jardiance |
| Abbvie INC. | $162.40 | 2022-2025 | |
| Amgen INC. | $139.97 | 2022-2023 | Prolia, Evenity |
| Abbott Laboratories | $90.90 | 2022-2024 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $88.47 | 2022-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $77.47 | 2021-2024 | Farxiga, Airsupra |
| Merck Sharp & Dohme LLC | $59.95 | 2023-2024 | Gardasil 9, Capvaxive, Gardasil |
| Novo Nordisk INC | $36.92 | 2023 | |
| Pfizer INC. | $36.28 | 2021-2024 | |
| Teva Pharmaceuticals USA, INC. | $28.80 | 2022 | |
| Radius Health, INC. | $19.01 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.21 | 2021 | |
| Dexcom, INC. | $13.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Pohlman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.